Literature DB >> 27142274

Cochlear implantation in recipients with single-sided deafness: Audiological performance.

Sebastian Hoth1, Maria Rösli-Khabas1, Ioana Herisanu1, Peter K Plinkert1, Mark Praetorius1.   

Abstract

OBJECTIVE: To examine the auditory benefit of cochlear implants (CI) in patients with single-sided deafness (SSD).
MATERIAL AND METHODS: Twenty patients with a normal pure tone audiogram (n = 8) or moderate hearing loss (n = 12) in one ear and a CI system MED-EL SONATA/CONCERTO + OPUS2 (n = 12), COCHLEAR CI24RE(ST) + CP810 (n = 7) and Advanced Bionics HiRes90 K + Harmony (n = 1) in the contralateral ear and with at least 6 months of CI experience were tested with respect to directional hearing, speech perception in noise, binaural loudness matching, and binaural pitch matching. Twenty-six normal hearing controls were included for normative reference.
RESULTS: Addition of the CI significantly improves directional hearing (percentage of correct source identifications improved from 14.9 to 15.6%, root mean square error decreased from 125 to 93°) and improves speech perception in noise (speech perception threshold median improved from -2.3 to -6.0 dB signal to noise ratio, equivalent to a binaural intelligibility level difference = 3.7 dB). Alternate binaural loudness balancing showed that matching takes place at levels between 48 and 55 dB HL (group averages). In the pitch matching experiment, the standard deviation of the relative interaural frequency difference at 500, 1000, and 2000 Hz was 24.5, 22.8, and 24.0%, respectively (compared to 11.7, 14.4, and 12.3% in the control group).
CONCLUSIONS: In SSD, cochlear implantation considerably improves audiological performance in terms of directional hearing, binaural signal equivalence, and speech perception.

Entities:  

Keywords:  Binaural matching; Cochlear implant; Directional hearing; SSD; Single-sided deafness; Speech perception; UHL; Unilateral hearing loss

Mesh:

Year:  2016        PMID: 27142274     DOI: 10.1080/14670100.2016.1176778

Source DB:  PubMed          Journal:  Cochlear Implants Int        ISSN: 1467-0100


  6 in total

1.  Patient benefit from Cochlear implantation in single-sided deafness: a 1-year follow-up.

Authors:  Julia Louza; John-Martin Hempel; Eike Krause; Alexander Berghaus; Joachim Müller; Thomas Braun
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-03-07       Impact factor: 2.503

2.  One-Year Results for Patients with Unilateral Hearing Loss and Accompanying Severe Tinnitus and Hyperacusis Treated with a Cochlear Implant.

Authors:  Angel Ramos Macías; Juan Carlos Falcón-González; Manuel Manrique Rodríguez; Constantino Morera Pérez; Luis García-Ibáñez; Carlos Cenjor Español; Chrystelle Coudert-Koall; Matthijs Killian
Journal:  Audiol Neurootol       Date:  2018-06-21       Impact factor: 1.854

3.  Hearing rehabilitation for unilateral deafness using a cochlear implant: the influence of the subjective duration of deafness on speech intelligibility.

Authors:  Tobias Rader; Oliver Julian Waleka; Sebastian Strieth; Klaus Wolfgang Georg Eichhorn; Andrea Bohnert; Dimitrios Koutsimpelas; Christoph Matthias; Benjamin Philipp Ernst
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-07-06       Impact factor: 2.503

4.  Effects of Cochlear Implantation on Binaural Hearing in Adults With Unilateral Hearing Loss.

Authors:  Emily Buss; Margaret T Dillon; Meredith A Rooth; English R King; Ellen J Deres; Craig A Buchman; Harold C Pillsbury; Kevin D Brown
Journal:  Trends Hear       Date:  2018 Jan-Dec       Impact factor: 3.293

5.  Simultaneous labyrinthectomy and cochlear implantation in unilateral meniere's disease.

Authors:  Elizabeth Perkins; Meredith Rooth; Margaret Dillon; Kevin Brown
Journal:  Laryngoscope Investig Otolaryngol       Date:  2018-05-14

6.  Core Rehabilitation Outcome Set for Single Sided Deafness (CROSSSD) study: protocol for an international consensus on outcome measures for single sided deafness interventions using a modified Delphi survey.

Authors:  Roulla Katiri; Deborah A Hall; Nora Buggy; Nicholas Hogan; Adele Horobin; Paul van de Heyning; Jill B Firszt; Iain A Bruce; Pádraig T Kitterick
Journal:  Trials       Date:  2020-03-04       Impact factor: 2.279

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.